Evidence map›Paper›PMID 26421087›Full record

ArticleBiomicrofluidics2015

An off-the-shelf integrated microfluidic device comprising self-assembled monolayers for protein array experiments.

Mirit Hen, Maria Ronen, Alex Deitch, Efrat Barbiro-Michaely, Ziv Oren, Chaim N Sukenik, Doron Gerber

Open access · bronzeAbstract read
In one paragraph

Article in Biomicrofluidics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mirit HenChemistry Department and Institute of Nanotechnology and Advanced Materials, Bar Ilan University , Ramat Gan 5290002, Israel.
Maria RonenMina and Everard Goodman Life Science Faculty and Institute of Nanotechnology and Advanced Materials, Bar Ilan University , Ramat Gan 5290002, Israel.
Alex DeitchMina and Everard Goodman Life Science Faculty and Institute of Nanotechnology and Advanced Materials, Bar Ilan University , Ramat Gan 5290002, Israel.
Efrat Barbiro-MichaelyMina and Everard Goodman Life Science Faculty and Institute of Nanotechnology and Advanced Materials, Bar Ilan University , Ramat Gan 5290002, Israel.
Ziv OrenIsrael Institute for Biological Research , P.O. Box 19, Nes Tziona 7410001, Israel.
Chaim N SukenikChemistry Department and Institute of Nanotechnology and Advanced Materials, Bar Ilan University , Ramat Gan 5290002, Israel.
Doron GerberMina and Everard Goodman Life Science Faculty and Institute of Nanotechnology and Advanced Materials, Bar Ilan University , Ramat Gan 5290002, Israel.
Bar-Ilan University · ILIsrael Institute for Biological Research · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic-based protein arrays are promising tools for life sciences, with increased sensitivity and specificity. One of the drawbacks of this technology is the need to create fresh surface chemistry for protein immobilization at the beginning of each experiment. In this work, we attempted to include the process of surface functionalization as part of the fabrication of the device, which would substitute the time consuming step of surface functionalization at the beginning of each protein array experiment. To this end, we employed a novel surface modification using self-assembled monolayers (SAMs) to immobilize biomolecules within the channels of a polydimethylsiloxane (PDMS) integrated microfluidic device. As a model, we present a general method for depositing siloxane-anchored SAMs, with 1-undecyl-thioacetate-trichlorosilane (C11TA) on the silica surfaces. The process involved developing PDMS-compatible conditions for both SAM deposition and functional group activation. We successfully demonstrated the ability to produce, within an integrated microfluidic channel, a C11TA monolayer with a covalently conjugated antibody. The antibody could then bind its antigen with a high signal to background ratio. We further demonstrated that the antibody was still active after storage of the device for a week. Integration of the surface chemistry into the device as part of its fabrication process has potential to significantly simplify and shorten many experimental procedures involving microfluidic-based protein arrays. In turn, this will allow for broader dissemination of this important technology.

Identifiers

PMID26421087
PMCPMC4575326
OpenAlexW2154831732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.